| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b1196ca0b21cef46477755512225dd8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C403-24 |
| filingDate |
1994-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30b462591624ffded5564168bdb66511 |
| publicationDate |
2001-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6251953-B1 |
| titleOfInvention |
Beta-carotene therapy of individuals having abnormal immunological and serological indices, and individuals having infections and diseases causing changes therein |
| abstract |
Methods for raising or maintaining the level of T4 cells in humans having a depressed T4 cell level and particularly in humans infected with HIV are provided. In these embodiments, T4 enhancing amounts of beta-carotene are administered. Methods are also provided for lowering or maintaining the levels of neopterin and/or beta2-microglobulin in humans having elevated levels of these indices and particularly in those infected with HIV. Beta-carotene is administered, respectively, in neopterin and beta2-microglobulin therapeutically effective amounts. Also contemplated by the present invention are methods for the prevention and/or treatment of HIV infection in humans. An HIV infection preventing or an anti-HIV therapeutically effective amount of beta-carotene is administered. In another embodiment, methods are provided for preventing or treating AIDS in humans. An AIDS preventing amount or an anti-AIDS therapeutically effective amount of beta-carotene is administered. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9993481-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10456369-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8211461-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10449247-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9216178-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003149098-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8003126-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018051297-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008090832-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7566714-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004223922-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8067416-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6759436-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010009996-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-201600093768-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007270581-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011217244-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005238675-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009052629-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9433624-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006040946-A1 |
| priorityDate |
1992-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |